ArticleNature communications2023

Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson's disease.

Wei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.